The Interferons market size is USD 10.72 Bn in 2026.
The Interferons market is projected to grow at a CAGR of 4% by 2033.
The Interferons market growth drivers include rising prevalence of chronic diseases, increasing cases of multiple sclerosis, and growing adoption of combination therapies.
North America is a dominating region for Interferons market.
Merck & Co., Inc., Biogen Inc., Novartis AG, Pfizer Inc., and Bayer AG are some leading industry players in the Interferons market.